(WASHINGTON, August 1, 2013)The American Society of Hematology (ASH) will present the 2013 William Dameshek Prize to Andrew S. Weyrich, PhD, of The University of Utah for his seminal research on the cellular and molecular causes of blood clots.
This prize, named after the late William Dameshek, MD, a renowned hematologist, past president of ASH, and the first editor of the Society's journal Blood, recognizes an individual who has made a recent, outstanding contribution to the field of hematology. Dr. Weyrich will accept his award at 9:30 a.m. on Tuesday, December 10, during the 55th ASH Annual Meeting and Exposition in New Orleans.
Dr. Weyrich, a Professor of Pathology and Internal Medicine at The University of Utah, began his medical career after earning his PhD in Physiology and Pharmacology from Wake Forest University's Bowman Gray School of Medicine in 1991. Following his training at Wake Forest, Dr. Weyrich held postdoctoral fellowships at Thomas Jefferson University and then at The University of Utah, where he remained as a faculty member after postdoctoral training. In 2007 Dr. Weyrich became a tenured Professor of Internal Medicine at The University of Utah School of Medicine, specializing in gross anatomy and gene expression.
Dr. Weyrich has dedicated his career to investigating the evolving role of platelets in inflammation and thrombosis. Among his major contributions to platelet biology research, Dr. Weyrich has successfully identified the mRNA splicing and translational mechanisms that allow platelets to respond to environmental changes. In a landmark discovery published in Cell in 2005, Dr. Weyrich and his team demonstrated that enucleated platelets contain functional spliceosome and cofactors, which are normally detected in nuclei of other cell types. Through this research, Dr. Weyrich determined that spliceosomal activity is vital in generating proinflammatory cytokines and factors critical for extrinsic
|Contact: Kaitlin Bressler|
American Society of Hematology